EUVIMEDEUVIMED entdecken
Open Access

Miniprotein engineering for inhibition of PD ‐1/ PD ‐ L1 interaction

Agnieszka Ciesiołkiewicz, Juan Lizandra Perez, Lukasz Skalniak, Paweł Noceń, Łukasz Berlicki iD

Protein Science · 2024

DOI: 10.1002/pro.5106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Science, 2024. Verfasst von Agnieszka Ciesiołkiewicz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioorganic Chemistry, Wrocław University of Science and Technology, Wrocław, Poland. Hauptthemen laut MEDLINE: Programmed Cell Death 1 Receptor, B7-H1 Antigen, Protein Engineering. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Science Centre, Poland, Narodowe Centrum Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Miniproteins constitute an excellent basis for the development of structurally demanding functional molecules. The engrailed homeodomain, a three‐helix‐containing miniprotein, was applied as a scaffold for constructing programmed cell death protein 1/programmed death‐ligand 1 (PD‐1/PD‐L1) interaction inhibitors. PD‐L1 binders were initially designed using the computer‐aided approach and subsequently optimized iteratively. The conformational stability was assessed for each obtained miniprotein using circular dichroism spectroscopy, indicating that numerous mutations could be introduced. The formation of a sizable hydrophobic surface at the inhibitor that fits the molecular target imposed the necessity for the incorporation of additional charged amino acid residues to retain its appropriate solubility. Finally, the miniprotein effectively binding to PD‐L1 ( K D = 51.4 nM) that inhibits PD‐1/PD‐L1 interaction in cell‐based studies with EC 50 = 3.9 μM, was discovered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Programmed Cell Death 1 ReceptorB7-H1 AntigenProtein EngineeringHumansProtein BindingModels, MolecularHomeodomain Proteins

Stichwörter der Autor:innen

cancercircular dichroismimmunotherapypeptidesprotein–protein interactions

Substanzen

Programmed Cell Death 1 ReceptorB7-H1 AntigenCD274 protein, humanPDCD1 protein, humanHomeodomain Proteins

Autor:innen und Institutionen

  • Department of Bioorganic Chemistry, Wrocław University of Science and Technology, Wrocław, Poland.
  • Faculty of Chemistry, Jagiellonian University, Kraków, Poland.

ORCID-Profile: Łukasz Berlicki

Förderung

  • National Science Centre, Poland
  • Narodowe Centrum Nauki

Zitieren

APA

Ciesiołkiewicz, A., Lizandra Perez, J., Skalniak, L., Noceń, P., & Berlicki, Ł. (2024). Miniprotein engineering for inhibition of PD ‐1/ PD ‐ L1 interaction. Protein Science. https://doi.org/10.1002/pro.5106

Vancouver

Ciesiołkiewicz A, Lizandra Perez J, Skalniak L, Noceń P, Berlicki Ł. Miniprotein engineering for inhibition of PD ‐1/ PD ‐ L1 interaction. Protein Science. 2024. doi:10.1002/pro.5106

BibTeX
@article{Ciesiokiewicz2024,
  author = {Ciesiołkiewicz, Agnieszka and Lizandra Perez, Juan and Skalniak, Lukasz and Noceń, Paweł and Berlicki, Łukasz},
  title = {Miniprotein engineering for inhibition of PD ‐1/ PD ‐ L1 interaction},
  journal = {Protein Science},
  year = {2024},
  doi = {10.1002/pro.5106}
}
Kostenlos starten →